You are here

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Emory University School of Medicine
Atlanta, Georgia, 30322-4510 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
TTR-CM
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
40 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patient successfully completed Protocol Fx1B-201.

- If female; patient is post menopausal. If male, female partner is post-menopausal. If
female is of child bearing potential, willing to use acceptable method of birth
control up to 3 months after last dose (included female partners of male
participants).

- Patient is willing to comply with protocol.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patient did not successfully complete Fx1B-201.

- Chronic use of NSAIDS.

- Patient has a clinically significant medication condition that increases risk of study
participation.

- Patient has received heart or liver transplant.

NCT00935012
Pfizer
Active, not recruiting
Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP), Transthyretin Cardiomyopathy (TTR-CM), Familial Amyloid Cardiomyopathy, Senile Systemic Amyloidosis (SSA)
NCT01604122
All Genders
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
NCT03842163
All Genders
50+
Years
A Coruna,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now